FindTrial
Sign In

Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation

PROCEDURE2 trials

Sponsors

Fred Hutchinson Cancer Center

Conditions

B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17pPlasma Cell LeukemiaProgression of Multiple Myeloma or Plasma Cell LeukemiaProlymphocytic LeukemiaRecurrent Adult Hodgkin LymphomaRecurrent Adult Non-Hodgkin Lymphoma

Phase 1

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
CompletedNCT00005803
Fred Hutchinson Cancer CenterProlymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma +11
Start: 1999-09-30End: 2018-10-31Updated: 2020-01-29

Phase 2

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
CompletedNCT01008462
Fred Hutchinson Cancer CenterB-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p +18
Start: 2010-03-18End: 2018-06-30Updated: 2019-06-11

Related Papers

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades
Haematologica2020-06-0435 citations